SLE-associated transverse myelitis successfully treated with Rituximab (anti-CD20 monoclonal antibody)

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Rheumatology international 2006-06, Vol.26 (8), p.771-772
Hauptverfasser:	ARMSTRONG, D. J, MCCARRON, M. T, WRIGHT, G. D
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenal Cortex Hormones - therapeutic use Anti-Inflammatory Agents - therapeutic use Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Murine-Derived Biological and medical sciences Cyclophosphamide - therapeutic use Diseases of the osteoarticular system Drug Therapy, Combination Female Follow-Up Studies Humans Immunosuppressive Agents - therapeutic use Lupus Erythematosus, Systemic - complications Medical sciences Middle Aged Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis Myelitis, Transverse - therapy Neurology Prednisolone - therapeutic use Rituximab Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!